While primary care clinicians play a crucial role in the care of patients with CKD, a holistic approach to care with multidisciplinary team involvement is essential.

Late identification of CKD in patients with T2D can lead to higher economic costs and increased risks of adverse events.

The current healthcare system values high procedural volumes over value-based care, which can impede on the management of chronic conditions like CKD and T2D.

An initiative in the Indian Health Service can serve as an example of how a systematic population-based approach can implemented for patients with CKD and T2D.

This is episode 6 of a 6-part podcast mini-series, organized and supported by Bayer, is intended for healthcare professionals practicing in the US. Our aim is to raise awareness of the importance of early diagnosis and appropriate management of chronic kidney disease (CKD) in patients with type 2 diabetes in order to slow progression of CKD and reduce the risk of premature cardiovascular morbidity and mortality.

Drs. Susanne B. Nicholas (Nephrologist and Professor of Medicine and Clinical Hypertension Specialist in the Division of Nephrology at UCLA), Radica Alicic (Internist and Clinical Professor at the University of Washington), and Nihar R. Desai (Cardiologist and Associate Professor of Medicine at Yale University) emphasize the key role of primary care clinicians in CKD management while highlighting the need for a multidisciplinary, holistic approach, as delayed CKD detection in T2D patients increases costs and risks.

Patient education and activation is important in early disease management, and includes self-care, monitoring, and adherence to treatment plans.

Patient support groups and resources are available for patients with CKD associated with T2D.

Early management of CKD associated with T2D offers numerous advantages.

This is episode 5 of a 6-part podcast mini-series, organized and supported by Bayer, is intended for healthcare professionals practicing in the US. Our aim is to raise awareness of the importance of early diagnosis and appropriate management of chronic kidney disease (CKD) in patients with type 2 diabetes in order to slow progression of CKD and reduce the risk of premature cardiovascular morbidity and mortality.

Drs. Susanne B. Nicholas (Nephrologist and Professor of Medicine and Clinical Hypertension Specialist in the Division of Nephrology at UCLA) and Jay H. Shubrook (Primary Care Physician/Diabetologist and Professor in the Primary Care Department at Touro University of California) discuss the importance of patient education and activation in early disease management and highlight the role of support groups and resources

American Diabetes Association (ADA) and Kidney Disease Improving Global Outcomes (KDIGO) emphasize the importance of comprehensive, patient-centered medical care for improved outcomes in patients.

Nonpharmaceutical strategies, such as lifestyle modifications, play a critical role in managing CKD associated with T2D.

ADA guidelines recommend diabetes self-management education and support (DSMES) for all individuals with diabetes.

Primary care clinicians play a critical role in the early identification and management of CKD and collaborative effort is needed to improve care of these patients.

This is episode 4 of a 6-part podcast mini-series, organized and supported by Bayer, is intended for healthcare professionals practicing in the US. Our aim is to raise awareness of the importance of early diagnosis and appropriate management of chronic kidney disease (CKD) in patients with type 2 diabetes in order to slow progression of CKD and reduce the risk of premature cardiovascular morbidity and mortality.

Drs. Radica Alicic (Internist and Clinical Professor at the University of Washington) and Jennifer B. Green (Endocrinologist and Professor of Medicine at Duke University Medical Center) emphasize the importance of patient-centered care, nonpharmaceutical strategies, and primary care clinicians' role in early CKD management, stressing collaboration to improve outcomes in T2D patients.